Bristol Myers Squibb, commonly known as BMS is a pharmaceutical company based in the United States. The company was founded in 1887 in Clinton, New York, the United States by William McLaren Bristol, E. R. Squibb, and John Ripley Myers. New York is also the primary Bristol Myers Squibb location. Bristol Myers Squibb agreed to pay around $2.5 billion in cash to buy Inhibitex Inc. in attempt to compete with Gilead / Pharmasset to produce hepatitis C drugs. Visit the Bristol Myers Squibb newsroom & stay up to date with our most current news as we continue to make a difference in the lives of our patients. PRINCETON, N.J.-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today reports results for the first quarter of 2025. “Our strong execution in the first quarter drove continued momentum across our Growth Portfolio and meaningful progress in the pipeline,” said Christopher Boerner, Ph.D., board chair and chief executive officer, Bristol Myers Squibb. “We are advancing our multi-year plan to become a more agile and efficient company, while strengthening the foundation for top-tier ...
